детипервичные иммунодефицитные состояниятрансплантация гемопоэтических стволовых клетокTCRaß+/CD19+ деплецияреакция «трансплантат против хозяина»childrenprimary immunodeficiencieshematopoietic stem cell transplantationTCRaß+/CD19+ depletiongraft-versus-host disease1.Fischer A. Human primary immunodeficiency diseases. Immunity. 2007; 27(6): 835-45.2.Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet. 1968; 2(7583): 1366-9.3.Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet. 1968; 2(7583): 1364-6.4.Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol. 2010; 126(3): 602-10.e1-11.5.Pai SY, Notarangelo LD. Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment. Immunol Allergy Clin North Am. 2010; 30(2): 179-94.6.Booth C, Gilmour KC, Veys P, Gennery AR, Slatter MA, Chapel, H et al. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood. 2011; 117(1): 53-62.7.Chakrabarti S, Milligan DW, Brown J, Osman H, Vipond IB, Pamphilon DH, et al. Influence of cytomegalovirus (CMV) sero-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: a comparison between two T-cell depletion regimens. Bone Marrow Transplant. 2004; 33(2): 197-204.8.Bacigalupo A, Mordini N, Pitto A, Piaggio G, Podestà M, Benvenuto F, et al. Transplantation of HLA-mismatched CD34+ selected cells in patients with advanced malignancies: severe immunodeficiency and related complications. Br J Haematol. 1997; 98(3): 760-6.9.Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med. 1998; 339(17): 1186-93.10.Bertaina A, Merli P, Rutella S, Pagliara D, Bernardo ME, Masetti R, et al. HLA-haploidentical stem cell transplantation after removal of aß+ T and B cells in children with nonmalignant disorders. Blood. 2014; 124(5): 822-6.11.Airoldi I, Bertaina A, Prigione I, Zorzoli A, Pagliara D, Cocco C, et al. γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-aß+/CD19+ lymphocytes. Blood. 2015; 125(15): 2349-58.12.Balashov D, Shcherbina A, Maschan M, Trakhtman P, Skvortsova Y, Shelikhova L, et al. Single-center experience of unrelated and haploidentical stem cell transplantation with TCRaß and CD19 depletion in children with primary immunodeficiency syndromes. Biol Blood Marrow Transplant. 2015; 21(11): 1955-62.13.Vantourout P, Hayday A. Six-of-the-best: unique contributions of γδ T cells to immunology. Nat Rev Immunol. 2013; 13(2): 88-100.14.Bekiaris V, Šedy JR, Ware CF. Mixing signals: molecular turn ons and turn offs for innate γδ T-cells. Front Immunol. 2014; 5: 654.15.Curtis RE, Travis LB, Rowlings PA, Socié G, Kingma DW, Banks PM, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999; 94(7): 2208-16.16.Chiang KY, Hazlett LJ, Godder KT, Abhyankar SH, Christiansen NP, van Rhee F, et al. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation. Bone Marrow Transplant. 2001; 28(12): 1117-23.17.Lang P, Teltschik HM, Feuchtinger T, Müller I, Pfeiffer M, Schumm M, et al. Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia. Br J Haematol. 2014; 165(5): 688-98.18.Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995; 15(6): 825-8.19.Grunebaum E, Mazzolari E, Porta F, Dallera D, Atkinson A, Reid B, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA. 2006: 295(5): 508-18.20.Slatter M, Nademi Z, Patel S, Barge D, Valappil M, Brigham K, et al. Haploidentical hematopoietic stem cell transplantation can lead to viral clearance in severe combined immunodeficiency. J Allergy Clin Immunol. 2013; 131(6): 1705-8.21.Dvorak CC, Hassan A, Slatter MA, Hönig M, Lankester AC, Buckley RH, et al. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency. J Allergy Clin Immunol. 2014; 134(4): 935-43.e15.22.Балашов ДН. Факторы риска и контроль вирусных инфекций после трансплантации гемопоэтических стволовых клеток. Автореф. дисс.. докт. мед. наук. М., 2011. / Balashov DN. Faktory riska i kontrol' virusnykh infektsii posle transplantatsii gemopoeticheskikh stvolovykh kletok. Avtoref. diss. dokt. med. nauk. Moscow, 2011. (In Russian).23.Laberko A, Maschan M, Shelikhova L, Balashov D, Skvortsova J, Boyakova E, et al. Analysis of risk factors of viral reactivation after haploidentical and matched unrelated hematopoietic stem cell transplantation with TCR alpha/beta and CD19 depletion. Bone Marrow Transplant. 2015; 50(Suppl. 1): S187-8. (41st Annual Meeting of the European Society for Blood and Marrow Transplantation, March, 22-25, 2015, Istanbul, Turkey).24.Hiwarkar P, Gajdosova E, Qasim W, Worth A, Breuer J, Chiesa R, et al. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients. Clin Infect Dis. 2014; 58(12): 1700-6.25.Cantoni N, Hirsch HH, Khanna N, Gerull S, Buser A, Bucher C, et al. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol Blood Marrow Transplant. 2010; 16(9): 1309-14.26.Handgretinger R. Negative depletion of CD3(+) and TcRaß(+) T cells. Curr Opin Hematol. 2012; 19(6): 434-9.27.Amrolia P, Gaspar HB, Hassan A, Webb D, Jones A, Sturt N, et al. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood. 2000; 96(4): 1239-46.28.Rao K, Amrolia PJ, Jones A, Cale CM, Naik P, King D, et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood. 2005: 105(2): 879-85.29.Oshrine BR, Olson TS, Bunin N. Mixed chimerism and graft loss in pediatric recipients of an alemtuzumab-based reduced-intensity conditioning regimen for non-malignant disease. Pediatr Blood Cancer. 2014; 61(10): 1852-9.30.Shaw BE, Byrne JL, Das-Gupta E, Carter GI, Russell NH. The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants. Biol Blood Marrow Transplant. 2007; 13(5): 550-9.